The use of hemodialysis in hypercalcemic crisis secondary to primary hyperparathyroidism
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , |
Tipo de documento: | Relatório |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692021000200123 |
Resumo: | ABSTRACT Severe hypercalcemia can be either acute or decompensate from a chronic state to a medical emergency, the hypercalcemic crisis. The presence of symptoms such as altered mental status or potentially fatal ECG abnormalities demand an expeditious decrease in serum calcium levels. Standard medical therapy consists of vigorous volume replacement, calcitonin and, depending on the etiology, bisphosphonates, cinacalcet or glucocorticoids. Hypercalcemic crisis is a rare indication for urgent hemodialysis and is reserved for patients with severe symptoms, ineffective medical therapy or end stage renal disease. The use of hemodialysis in this scenario is not commonly reported. We hereby report a patient who presented with altered mental status and acute kidney injury due to a hypercalcemic crisis secondary to primary hyperparathyroidism. Treatment included urgent hemodialysis to effectively lower calcium levels. |
id |
RCAP_68910213c652bea60aba62e0fa5dda4c |
---|---|
oai_identifier_str |
oai:scielo:S0872-01692021000200123 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
The use of hemodialysis in hypercalcemic crisis secondary to primary hyperparathyroidismhypercalcemiaprimary hyperparathyroidismhemodialysis.ABSTRACT Severe hypercalcemia can be either acute or decompensate from a chronic state to a medical emergency, the hypercalcemic crisis. The presence of symptoms such as altered mental status or potentially fatal ECG abnormalities demand an expeditious decrease in serum calcium levels. Standard medical therapy consists of vigorous volume replacement, calcitonin and, depending on the etiology, bisphosphonates, cinacalcet or glucocorticoids. Hypercalcemic crisis is a rare indication for urgent hemodialysis and is reserved for patients with severe symptoms, ineffective medical therapy or end stage renal disease. The use of hemodialysis in this scenario is not commonly reported. We hereby report a patient who presented with altered mental status and acute kidney injury due to a hypercalcemic crisis secondary to primary hyperparathyroidism. Treatment included urgent hemodialysis to effectively lower calcium levels.Sociedade Portuguesa de Nefrologia2021-06-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/reporttext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692021000200123Portuguese Journal of Nephrology & Hypertension v.35 n.2 2021reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692021000200123Marouço,Catarina NazárioCaeiro,FernandoCosta,Bernardo Marques daNavarro,DavidMagriço,RitaNolasco,Fernandoinfo:eu-repo/semantics/openAccess2024-02-06T17:05:10Zoai:scielo:S0872-01692021000200123Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T02:19:06.084432Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
The use of hemodialysis in hypercalcemic crisis secondary to primary hyperparathyroidism |
title |
The use of hemodialysis in hypercalcemic crisis secondary to primary hyperparathyroidism |
spellingShingle |
The use of hemodialysis in hypercalcemic crisis secondary to primary hyperparathyroidism Marouço,Catarina Nazário hypercalcemia primary hyperparathyroidism hemodialysis. |
title_short |
The use of hemodialysis in hypercalcemic crisis secondary to primary hyperparathyroidism |
title_full |
The use of hemodialysis in hypercalcemic crisis secondary to primary hyperparathyroidism |
title_fullStr |
The use of hemodialysis in hypercalcemic crisis secondary to primary hyperparathyroidism |
title_full_unstemmed |
The use of hemodialysis in hypercalcemic crisis secondary to primary hyperparathyroidism |
title_sort |
The use of hemodialysis in hypercalcemic crisis secondary to primary hyperparathyroidism |
author |
Marouço,Catarina Nazário |
author_facet |
Marouço,Catarina Nazário Caeiro,Fernando Costa,Bernardo Marques da Navarro,David Magriço,Rita Nolasco,Fernando |
author_role |
author |
author2 |
Caeiro,Fernando Costa,Bernardo Marques da Navarro,David Magriço,Rita Nolasco,Fernando |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Marouço,Catarina Nazário Caeiro,Fernando Costa,Bernardo Marques da Navarro,David Magriço,Rita Nolasco,Fernando |
dc.subject.por.fl_str_mv |
hypercalcemia primary hyperparathyroidism hemodialysis. |
topic |
hypercalcemia primary hyperparathyroidism hemodialysis. |
description |
ABSTRACT Severe hypercalcemia can be either acute or decompensate from a chronic state to a medical emergency, the hypercalcemic crisis. The presence of symptoms such as altered mental status or potentially fatal ECG abnormalities demand an expeditious decrease in serum calcium levels. Standard medical therapy consists of vigorous volume replacement, calcitonin and, depending on the etiology, bisphosphonates, cinacalcet or glucocorticoids. Hypercalcemic crisis is a rare indication for urgent hemodialysis and is reserved for patients with severe symptoms, ineffective medical therapy or end stage renal disease. The use of hemodialysis in this scenario is not commonly reported. We hereby report a patient who presented with altered mental status and acute kidney injury due to a hypercalcemic crisis secondary to primary hyperparathyroidism. Treatment included urgent hemodialysis to effectively lower calcium levels. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-06-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/report |
format |
report |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692021000200123 |
url |
http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692021000200123 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692021000200123 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Portuguesa de Nefrologia |
publisher.none.fl_str_mv |
Sociedade Portuguesa de Nefrologia |
dc.source.none.fl_str_mv |
Portuguese Journal of Nephrology & Hypertension v.35 n.2 2021 reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799137280780140544 |